D. E. Shaw & Co., Inc. Reata Pharmaceuticals Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.97 Million - $2.75 Million	15,600 Added 255.74%	21,700 $3.39 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $1.08 Million - $1.31 Million	-13,900 Reduced 69.5%	6,100 $576,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $975,200 - $1.53 Million	20,000 New	20,000 $1.12 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.